2 weeks Ago By ABMN Staff
InMed Pharmaceuticals Inc. ( NASDAQ:INM – Get Free Report ) was the target of a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 534,900 shares, a growth of 55.
3% from the August 31st total of 344,500 shares. Based on an average daily trading volume, of 6,890,000 shares, the short-interest ratio is presently 0.1 days.
InMed Pharmaceuticals Stock Performance Shares of InMed Pharmaceuticals stock opened at $0.23 on Friday. InMed Pharmaceuticals has a one year low of $0.
12 and a one year high of $2.08. The company has a debt-to-equity ratio of 0.
07, a quick ratio of 5.80 and a current ratio of 6.58.
The firm has a fifty day moving average of $0.26 and a two-hundred day moving average of $0.28.
Institutional Inflows and Outflows A hedge fund recently bought a new stake in InMed Pharmaceuticals stock. Armistice Capital LLC purchased a new position in shares of InMed Pharmaceuticals Inc. ( NASDAQ:INM – Free Report ) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission.
The institutional investor purchased 205,968 shares of the company’s stock, valued at approximately $86,000. Armistice Capital LLC owned 3.92% of InMed Pharmaceuticals as of its most recent SEC filing.
Institutional investors and hedge funds own 20.12% of the company’s stock. About InMed Pharmaceuticals InMed Pharmaceuticals Inc, a clinical stage pharmaceutical company, develops a pipeline of prescription-based products.
The company operates through two segments, the InMed and the BayMedica. The InMed segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry.
See Also Receive News & Ratings for InMed Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMed Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter ..
